ANDECALIXIMAB (ANTI-MMP9) INDUCTION THERAPY FOR CROHN’S DISEASE: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 STUDY

Stefan Schreiber  1     Corey A Siegel  2     Keith Friedenberg  3     Ursula Seidler  4     Bal R. Bhandari  5     Ziad Younes  6     KE WANG  7     Matthew McKevitt     Sally Zhao     Bittoo Kanwar     John Sundy     Scott D. Lee     Edward V Loftus Jr    
1 Christian-Albrechts-University Kiel,Kiel,Germany
2 Dartmouth-Hitchcock Medical Center,Lebanon,United States of America
3 Great Lakes Gastroenterology,Mentor,United States of America
4 Hannover Medical School,Hannover,Germany
5 Delta Research Partners,Monroe,United States of America
6 GastroOne,Germantown,United States of America
7 Gilead S

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at office@ueg.eu

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing